PET/computed tomography and patient outcomes in melanoma

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


The performance of fludeoxyglucose F 18 (FDG)-PET/computed tomography (CT) in the initial and follow-up evaluation of patients with melanoma is well established. Groups are beginning to investigate whether the inclusion of FDG-PET/CT into a staging or surveillance algorithm results in an improvement in patient outcome and whether such an imaging program would be cost-effective.

Original languageEnglish (US)
Pages (from-to)243-254
Number of pages12
JournalPET Clinics
Issue number2
StatePublished - Apr 1 2015


  • Melanoma
  • Outcomes
  • PET/CT
  • Surveillance

ASJC Scopus subject areas

  • Radiation
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'PET/computed tomography and patient outcomes in melanoma'. Together they form a unique fingerprint.

Cite this